SeaSpine
Net sales: $47.5 million (+66 percent)
U.S. sales: $42.6 million (+64 percent)
U.S. spinal implants and enabling technologies sales: $21.4 million (+62 percent)
U.S. orthobiologics sales: $21.2 million (+67 percent)
Orthofix
Net sales: $121 million (+66 percent)
Global spine sales: $94.7 million (+62.5 percent)
Global orthopedic sales: $26.7 million (+66 percent)
Smith+Nephew
Net sales: $1.3 million (+48.2 percent)
Orthopedic sales: $557 million (+53 percent)
Knee sales: $226 million (+65.5 percent)
Hip sales: $161 million (+43.6 percent)
Trauma and extremities sales: $149 milloin (+44.3 percent)
Sports medicine joint repair sales: $211 million (+63.6 percent)
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
